nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—Eyelid oedema—Formoterol—chronic obstructive pulmonary disease	0.0478	0.0689	CcSEcCtD
Levocabastine—Eyelid oedema—Arformoterol—chronic obstructive pulmonary disease	0.0478	0.0689	CcSEcCtD
Levocabastine—NTSR2—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0343	0.112	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.0161	0.0525	CbGpPWpGaD
Levocabastine—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.0161	0.0233	CcSEcCtD
Levocabastine—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.0149	0.0215	CcSEcCtD
Levocabastine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.0146	0.0211	CcSEcCtD
Levocabastine—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.0145	0.0209	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.0126	0.0411	CbGpPWpGaD
Levocabastine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0122	0.0175	CcSEcCtD
Levocabastine—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.012	0.0173	CcSEcCtD
Levocabastine—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.012	0.0173	CcSEcCtD
Levocabastine—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.0118	0.017	CcSEcCtD
Levocabastine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.0117	0.0168	CcSEcCtD
Levocabastine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.0117	0.0168	CcSEcCtD
Levocabastine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.0114	0.0164	CcSEcCtD
Levocabastine—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.0113	0.0164	CcSEcCtD
Levocabastine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.0109	0.0157	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.0108	0.0352	CbGpPWpGaD
Levocabastine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0107	0.0154	CcSEcCtD
Levocabastine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0107	0.0154	CcSEcCtD
Levocabastine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0106	0.0153	CcSEcCtD
Levocabastine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0101	0.0145	CcSEcCtD
Levocabastine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.01	0.0144	CcSEcCtD
Levocabastine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00919	0.0133	CcSEcCtD
Levocabastine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00919	0.0133	CcSEcCtD
Levocabastine—NTSR2—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00915	0.0298	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00904	0.0294	CbGpPWpGaD
Levocabastine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00901	0.013	CcSEcCtD
Levocabastine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00877	0.0127	CcSEcCtD
Levocabastine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00877	0.0127	CcSEcCtD
Levocabastine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00868	0.0125	CcSEcCtD
Levocabastine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00828	0.012	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00823	0.0268	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00819	0.0266	CbGpPWpGaD
Levocabastine—NTSR2—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00801	0.0261	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00792	0.0258	CbGpPWpGaD
Levocabastine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00767	0.0111	CcSEcCtD
Levocabastine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00767	0.0111	CcSEcCtD
Levocabastine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00764	0.011	CcSEcCtD
Levocabastine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00764	0.011	CcSEcCtD
Levocabastine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00749	0.0108	CcSEcCtD
Levocabastine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00741	0.0107	CcSEcCtD
Levocabastine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00741	0.0107	CcSEcCtD
Levocabastine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00735	0.0106	CcSEcCtD
Levocabastine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00735	0.0106	CcSEcCtD
Levocabastine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00726	0.0105	CcSEcCtD
Levocabastine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00724	0.0104	CcSEcCtD
Levocabastine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00722	0.0104	CcSEcCtD
Levocabastine—Pain—Montelukast—chronic obstructive pulmonary disease	0.0072	0.0104	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00716	0.0233	CbGpPWpGaD
Levocabastine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00712	0.0103	CcSEcCtD
Levocabastine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00712	0.0103	CcSEcCtD
Levocabastine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00708	0.0102	CcSEcCtD
Levocabastine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.007	0.0101	CcSEcCtD
Levocabastine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00694	0.01	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00678	0.0221	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00674	0.022	CbGpPWpGaD
Levocabastine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00672	0.0097	CcSEcCtD
Levocabastine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00671	0.00969	CcSEcCtD
Levocabastine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00671	0.00969	CcSEcCtD
Levocabastine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00668	0.00964	CcSEcCtD
Levocabastine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00633	0.00914	CcSEcCtD
Levocabastine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00632	0.00912	CcSEcCtD
Levocabastine—HRH1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.00622	0.0203	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00619	0.0201	CbGpPWpGaD
Levocabastine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00617	0.00891	CcSEcCtD
Levocabastine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00617	0.00891	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00606	0.0197	CbGpPWpGaD
Levocabastine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00604	0.00872	CcSEcCtD
Levocabastine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00583	0.00841	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00577	0.0188	CbGpPWpGaD
Levocabastine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00571	0.00824	CcSEcCtD
Levocabastine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00542	0.00783	CcSEcCtD
Levocabastine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00542	0.00783	CcSEcCtD
Levocabastine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00542	0.00782	CcSEcCtD
Levocabastine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00542	0.00782	CcSEcCtD
Levocabastine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00539	0.00778	CcSEcCtD
Levocabastine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00539	0.00778	CcSEcCtD
Levocabastine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00531	0.00767	CcSEcCtD
Levocabastine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00531	0.00766	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.0053	0.0173	CbGpPWpGaD
Levocabastine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00528	0.00762	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00524	0.0171	CbGpPWpGaD
Levocabastine—HRH1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.00523	0.017	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00517	0.0168	CbGpPWpGaD
Levocabastine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00512	0.00739	CcSEcCtD
Levocabastine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00511	0.00738	CcSEcCtD
Levocabastine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00511	0.00737	CcSEcCtD
Levocabastine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00511	0.00737	CcSEcCtD
Levocabastine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00509	0.00734	CcSEcCtD
Levocabastine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.005	0.00722	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00488	0.0159	CbGpPWpGaD
Levocabastine—HRH1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00486	0.0158	CbGpPWpGaD
Levocabastine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00482	0.00696	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00465	0.0151	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00462	0.015	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00423	0.0138	CbGpPWpGaD
Levocabastine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00415	0.00599	CcSEcCtD
Levocabastine—HRH1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.00409	0.0133	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00409	0.0133	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00404	0.0131	CbGpPWpGaD
Levocabastine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00398	0.00575	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00328	0.0107	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.00323	0.0105	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.0031	0.0101	CbGpPWpGaD
Levocabastine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00294	0.00424	CcSEcCtD
Levocabastine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00293	0.00423	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00292	0.0095	CbGpPWpGaD
Levocabastine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00292	0.00421	CcSEcCtD
Levocabastine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00292	0.00421	CcSEcCtD
Levocabastine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00277	0.00399	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00265	0.00863	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00261	0.00849	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.0025	0.00812	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00249	0.00812	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00249	0.00809	CbGpPWpGaD
Levocabastine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00243	0.0035	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00237	0.00771	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.00228	0.00743	CbGpPWpGaD
Levocabastine—Rash—Prednisone—chronic obstructive pulmonary disease	0.00213	0.00308	CcSEcCtD
Levocabastine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00213	0.00308	CcSEcCtD
Levocabastine—Headache—Prednisone—chronic obstructive pulmonary disease	0.00212	0.00306	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00207	0.00674	CbGpPWpGaD
Levocabastine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00201	0.0029	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00191	0.00623	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.00183	0.00594	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.0017	0.00552	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00164	0.00534	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00157	0.0051	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00141	0.00459	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.0014	0.00455	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00139	0.00452	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.00128	0.00417	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.00127	0.00414	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00125	0.00407	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00124	0.00404	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00122	0.00398	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00121	0.00395	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.0012	0.00391	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.00114	0.0037	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00109	0.00354	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00103	0.00335	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00102	0.00333	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000939	0.00306	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000936	0.00305	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000919	0.00299	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000893	0.00291	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000876	0.00285	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000853	0.00277	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000804	0.00262	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000795	0.00259	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000783	0.00255	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000756	0.00246	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000719	0.00234	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000706	0.0023	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.0007	0.00228	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000684	0.00223	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000641	0.00209	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00062	0.00202	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000614	0.002	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000612	0.00199	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000564	0.00183	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000553	0.0018	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000497	0.00162	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.00049	0.0016	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00047	0.00153	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000464	0.00151	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000443	0.00144	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000425	0.00138	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000402	0.00131	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000396	0.00129	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000379	0.00123	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000378	0.00123	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000377	0.00123	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000359	0.00117	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000346	0.00113	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000314	0.00102	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000277	0.000901	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000257	0.000838	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000238	0.000773	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000214	0.000696	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000212	0.000691	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000194	0.000632	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000193	0.000628	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000186	0.000604	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000173	0.000562	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000142	0.000462	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000135	0.000441	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000129	0.000421	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000115	0.000373	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000109	0.000355	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000104	0.000338	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.32e-05	0.000303	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.55e-05	0.000278	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.38e-05	0.000273	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.04e-05	0.000229	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.44e-05	0.00021	CbGpPWpGaD
